EA201990109A1 - Митохондриальные ингибиторы для лечения пролиферативных нарушений - Google Patents
Митохондриальные ингибиторы для лечения пролиферативных нарушенийInfo
- Publication number
- EA201990109A1 EA201990109A1 EA201990109A EA201990109A EA201990109A1 EA 201990109 A1 EA201990109 A1 EA 201990109A1 EA 201990109 A EA201990109 A EA 201990109A EA 201990109 A EA201990109 A EA 201990109A EA 201990109 A1 EA201990109 A1 EA 201990109A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- proliferative disorders
- mitochondrial inhibitors
- compounds
- mitochondrial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Настоящее изобретение предусматривает соединения формулы I или их фармацевтически приемлемые соли, сольваты или гидратыгде кольцо A представляет собой группу A-I или A-IIпри этом A, A, A, Aнезависимо представляют собой C(R) или N, при этом не более чем один из A, A, Aи Aпредставляет собой N; Aпредставляет собой C(R) или N; B, B, Bи Bнезависимо представляют собой C(R) или N, при этом не более чем два из B, B, Bи Bпредставляют собой N; n равняется 1 или 2; и R, R, R, R, и R, и Rопределены в формуле изобретения, а также способы применения соединений для лечения пролиферативных заболеваний, в частности рака.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16177193 | 2016-06-30 | ||
PCT/EP2017/066129 WO2018002220A1 (en) | 2016-06-30 | 2017-06-29 | Mitochondrial inhibitors for the treatment of proliferation disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201990109A1 true EA201990109A1 (ru) | 2019-07-31 |
Family
ID=56321804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990109A EA201990109A1 (ru) | 2016-06-30 | 2017-06-29 | Митохондриальные ингибиторы для лечения пролиферативных нарушений |
Country Status (13)
Country | Link |
---|---|
US (1) | US20190142810A1 (ru) |
EP (1) | EP3478678A1 (ru) |
JP (1) | JP2019520372A (ru) |
KR (1) | KR20190022728A (ru) |
CN (1) | CN109661392A (ru) |
AU (1) | AU2017289318A1 (ru) |
BR (1) | BR112018076258A2 (ru) |
CA (1) | CA3024918A1 (ru) |
EA (1) | EA201990109A1 (ru) |
IL (1) | IL263862A (ru) |
MX (1) | MX2018015548A (ru) |
TW (1) | TW201806939A (ru) |
WO (1) | WO2018002220A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200119807A (ko) | 2018-01-11 | 2020-10-20 | 켄타우루스 테라퓨틱스 | 질병 치료를 위한 디하이드로세라마이드 불포화화효소의 저해제 |
EP3837263A1 (en) | 2018-08-13 | 2021-06-23 | F. Hoffmann-La Roche AG | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
EP4334289A1 (en) * | 2021-05-07 | 2024-03-13 | Organon R&D Finland Ltd | Novel heterocyclic compounds, compositions, methods of preparation and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ME02222B (me) * | 2004-12-30 | 2016-02-20 | Janssen Pharmaceutica Nv | Amid derivati piperidin-i piperazin-1-karboksilne kiseline te povezani spojevi kao modulatori amid hidrolaze masnih kiselina (faah) za liječenje tjeskobe, boli i drugih stanja |
BRPI0921257A2 (pt) | 2008-11-14 | 2016-02-23 | Bayer Schering Pharma Ag | composto de arila heterociclicamente subsittuidos como inibidores hif |
EP2888256A4 (en) | 2012-08-24 | 2016-02-17 | Univ Texas | HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES |
NZ704799A (en) * | 2012-08-24 | 2018-06-29 | Univ Texas | Heterocyclic modulators of hif activity for treatment of disease |
WO2014179144A1 (en) * | 2013-04-29 | 2014-11-06 | E. I. Du Pont De Nemours And Company | Fungicidal heterocyclic compounds |
TW201927302A (zh) * | 2017-10-12 | 2019-07-16 | 瑞士商巴塞利亞藥業國際股份有限公司 | 用於治療增殖障礙之線粒體抑制劑 |
TW201927767A (zh) * | 2017-12-14 | 2019-07-16 | 瑞士商巴塞利亞藥業國際股份有限公司 | 用於治療增生性障礙之線粒體抑制劑 |
-
2017
- 2017-06-29 CA CA3024918A patent/CA3024918A1/en not_active Abandoned
- 2017-06-29 AU AU2017289318A patent/AU2017289318A1/en not_active Abandoned
- 2017-06-29 EA EA201990109A patent/EA201990109A1/ru unknown
- 2017-06-29 TW TW106121721A patent/TW201806939A/zh unknown
- 2017-06-29 BR BR112018076258A patent/BR112018076258A2/pt not_active Application Discontinuation
- 2017-06-29 US US16/310,918 patent/US20190142810A1/en not_active Abandoned
- 2017-06-29 EP EP17732948.9A patent/EP3478678A1/en not_active Withdrawn
- 2017-06-29 KR KR1020197002305A patent/KR20190022728A/ko unknown
- 2017-06-29 WO PCT/EP2017/066129 patent/WO2018002220A1/en unknown
- 2017-06-29 CN CN201780051287.2A patent/CN109661392A/zh active Pending
- 2017-06-29 JP JP2018568897A patent/JP2019520372A/ja active Pending
- 2017-06-29 MX MX2018015548A patent/MX2018015548A/es unknown
-
2018
- 2018-12-20 IL IL263862A patent/IL263862A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2017289318A1 (en) | 2018-11-29 |
WO2018002220A1 (en) | 2018-01-04 |
KR20190022728A (ko) | 2019-03-06 |
JP2019520372A (ja) | 2019-07-18 |
MX2018015548A (es) | 2019-04-11 |
TW201806939A (zh) | 2018-03-01 |
BR112018076258A2 (pt) | 2019-03-26 |
EP3478678A1 (en) | 2019-05-08 |
CN109661392A (zh) | 2019-04-19 |
CA3024918A1 (en) | 2018-01-04 |
IL263862A (en) | 2019-01-31 |
US20190142810A1 (en) | 2019-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP19052302A (es) | Derivados de benzooxazol como inmunomoduladores | |
EA201890308A1 (ru) | Замещенные азасоединения как ингибиторы irak-4 | |
CO2018005640A2 (es) | Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria | |
EA201792214A1 (ru) | Соединения замещенного хиназолина | |
ECSP17070706A (es) | Inhibidores de bromodominio | |
CL2020000886A1 (es) | Derivados de 1-benzil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de la proteasa del vih. | |
EA201891191A1 (ru) | 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения | |
EA201591339A1 (ru) | Тиазолкарбоксамиды и пиридинкарбоксамиды, используемые в качестве ингибиторов pim-киназы | |
EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
EA201790078A1 (ru) | Ингибиторы mnk и связанные с ними способы | |
EA201792231A1 (ru) | Ингибиторы индоламин-2,3-диоксигеназы и способы их применения | |
NI201600165A (es) | Inhibidores de desmetilasa 1 específica a lisina | |
EA201792259A1 (ru) | Бензимидазольные и имидазопиридиновые карбоксимидамидные соединения | |
EA201792116A1 (ru) | Ингибитор янус-киназы | |
EA201992884A2 (ru) | Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний | |
EA201790764A1 (ru) | Новые соединения карбоновых кислот, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
EA201790317A1 (ru) | Ингибиторы smyd | |
EA201791576A1 (ru) | Ингибитор jak | |
EA201790740A1 (ru) | Индолкарбоксамидные соединения | |
EA201691803A1 (ru) | Ингибиторы калликреина плазмы человека | |
EA201692268A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
EA201790660A1 (ru) | Ингибитор киназ | |
CO2021002977A2 (es) | Dimetilaminoazetidinaminas como inhibidores de jak | |
CO2021002976A2 (es) | Amidas heterocíclicas de 5 a 7 miembros como inhibidores de jak | |
SV2017005381A (es) | Compuestos de imidazopiridazina |